 | • レポートコード：QAF27567 • 出版社/出版日：QYResearch / 2021年5月28日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、135ページ • 納品方法：Eメール（即日納品） • 産業分類：医薬品 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本市場調査資料では、世界の抗感染性眼炎市場について種類別（抗菌、抗ウイルス、抗真菌、抗寄生虫、その他）、用途別（病院、診療所、家庭用、その他）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・抗感染性眼炎市場の概要 ・世界の主要地域別抗感染性眼炎市場規模2016-2027 ・主要プレイヤーの競争状況・市場シェア ・世界の抗感染性眼炎市場規模2016-2021：種類別（抗菌、抗ウイルス、抗真菌、抗寄生虫、その他） ・世界の抗感染性眼炎市場予測2012-2027：種類別（抗菌、抗ウイルス、抗真菌、抗寄生虫、その他） ・世界の抗感染性眼炎市場規模2016-2021：用途別（病院、診療所、家庭用、その他） ・世界の抗感染性眼炎市場予測2012-2027：用途別（病院、診療所、家庭用、その他） ・抗感染性眼炎のアメリカ市場規模と予測2016-2021 ・抗感染性眼炎のヨーロッパ市場規模と予測2016-2021 ・抗感染性眼炎の中国市場規模と予測2016-2021 ・抗感染性眼炎の日本市場規模と予測2016-2021 ・抗感染性眼炎の東南アジア市場規模と予測2016-2021 ・抗感染性眼炎のインド市場規模と予測2016-2021 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Novartis、Allergan、Bausch Health、Santen Pharmaceutical、Lupin Pharmaceuticals、Apotex、Akorn） ・抗感染性眼炎の製造コスト分析 ・販売チャネル、流通業者、顧客 ・抗感染性眼炎の市場動向・機会・課題 ・調査の結論 |
Ophthalmic anti-infectives are anti-infectives contained in a product formulated especially to be instilled or applied in the eye or eyes. Ophthalmic anti-infectives include eyedrops, gels or ointments. Anti-infectives are drugs that can either kill an infectious agent or inhibit it from spreading. Anti-infectives include antibiotics and antibacterials, antifungals, antivirals and antiprotozoals.
In terms of region, the global ophthalmic anti-infective market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected to dominate the global ophthalmic anti-infective market due to availability of advanced drug formulations in the region. Awareness among people about diseases is also a major factor boosting the market in the region. The ophthalmic anti-infective market in Asia Pacific is anticipated to expand at a rapid pace due to increase in incidence of eye infection in the region. Lack of awareness about diseases and unavailability of advanced medication and formulations in underdeveloped countries, such as Lebanon, Syria, Cyprus, Turkey, and Iraq are likely to restrain the growth of the ophthalmic anti-infective market in Middle East & Africa.
Market Analysis and Insights: Global Anti-Infective Ophthalmic Market
The global Anti-Infective Ophthalmic market was valued at US$ 1468.1 in 2020 and will reach US$ 1558.4 million by the end of 2027, growing at a CAGR of 1.0% during 2022-2027.
Global Anti-Infective Ophthalmic Scope and Market Size
The global Anti-Infective Ophthalmic market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Anti-Infective Ophthalmic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Antibacterial
Antiviral
Antifungal
Anti-Parasitic
Others
Segment by Application
Hospital
Clinic
Household
Others
The Anti-Infective Ophthalmic market is analysed and market size information is provided by regions (countries). Segment by Application, the Anti-Infective Ophthalmic market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Novartis
Allergan
Bausch Health
Santen Pharmaceutical
Lupin Pharmaceuticals
Apotex
Akorn
1 Anti-Infective Ophthalmic Market Overview
1.1 Anti-Infective Ophthalmic Product Scope
1.2 Anti-Infective Ophthalmic Segment by Type
1.2.1 Global Anti-Infective Ophthalmic Sales by Type (2016 & 2021 & 2027)
1.2.2 Antibacterial
1.2.3 Antiviral
1.2.4 Antifungal
1.2.5 Anti-Parasitic
1.2.6 Others
1.3 Anti-Infective Ophthalmic Segment by Application
1.3.1 Global Anti-Infective Ophthalmic Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Household
1.3.5 Others
1.4 Anti-Infective Ophthalmic Market Estimates and Forecasts (2016-2027)
1.4.1 Global Anti-Infective Ophthalmic Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Anti-Infective Ophthalmic Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Anti-Infective Ophthalmic Price Trends (2016-2027)
2 Anti-Infective Ophthalmic Estimates and Forecasts by Region
2.1 Global Anti-Infective Ophthalmic Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Anti-Infective Ophthalmic Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Anti-Infective Ophthalmic Sales Market Share by Region (2016-2021)
2.2.2 Global Anti-Infective Ophthalmic Revenue Market Share by Region (2016-2021)
2.3 Global Anti-Infective Ophthalmic Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Anti-Infective Ophthalmic Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Anti-Infective Ophthalmic Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Anti-Infective Ophthalmic Estimates and Projections (2016-2027)
2.4.2 Europe Anti-Infective Ophthalmic Estimates and Projections (2016-2027)
2.4.3 China Anti-Infective Ophthalmic Estimates and Projections (2016-2027)
2.4.4 Japan Anti-Infective Ophthalmic Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Anti-Infective Ophthalmic Estimates and Projections (2016-2027)
2.4.6 India Anti-Infective Ophthalmic Estimates and Projections (2016-2027)
3 Global Anti-Infective Ophthalmic Competition Landscape by Players
3.1 Global Top Anti-Infective Ophthalmic Players by Sales (2016-2021)
3.2 Global Top Anti-Infective Ophthalmic Players by Revenue (2016-2021)
3.3 Global Anti-Infective Ophthalmic Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Anti-Infective Ophthalmic as of 2020)
3.4 Global Anti-Infective Ophthalmic Average Price by Company (2016-2021)
3.5 Manufacturers Anti-Infective Ophthalmic Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Anti-Infective Ophthalmic Market Size by Type
4.1 Global Anti-Infective Ophthalmic Historic Market Review by Type (2016-2021)
4.1.1 Global Anti-Infective Ophthalmic Sales Market Share by Type (2016-2021)
4.1.2 Global Anti-Infective Ophthalmic Revenue Market Share by Type (2016-2021)
4.1.3 Global Anti-Infective Ophthalmic Price by Type (2016-2021)
4.2 Global Anti-Infective Ophthalmic Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Anti-Infective Ophthalmic Sales Forecast by Type (2022-2027)
4.2.2 Global Anti-Infective Ophthalmic Revenue Forecast by Type (2022-2027)
4.2.3 Global Anti-Infective Ophthalmic Price Forecast by Type (2022-2027)
5 Global Anti-Infective Ophthalmic Market Size by Application
5.1 Global Anti-Infective Ophthalmic Historic Market Review by Application (2016-2021)
5.1.1 Global Anti-Infective Ophthalmic Sales Market Share by Application (2016-2021)
5.1.2 Global Anti-Infective Ophthalmic Revenue Market Share by Application (2016-2021)
5.1.3 Global Anti-Infective Ophthalmic Price by Application (2016-2021)
5.2 Global Anti-Infective Ophthalmic Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Anti-Infective Ophthalmic Sales Forecast by Application (2022-2027)
5.2.2 Global Anti-Infective Ophthalmic Revenue Forecast by Application (2022-2027)
5.2.3 Global Anti-Infective Ophthalmic Price Forecast by Application (2022-2027)
6 North America Anti-Infective Ophthalmic Market Facts & Figures
6.1 North America Anti-Infective Ophthalmic Sales by Company
6.1.1 North America Anti-Infective Ophthalmic Sales by Company (2016-2021)
6.1.2 North America Anti-Infective Ophthalmic Revenue by Company (2016-2021)
6.2 North America Anti-Infective Ophthalmic Sales Breakdown by Type
6.2.1 North America Anti-Infective Ophthalmic Sales Breakdown by Type (2016-2021)
6.2.2 North America Anti-Infective Ophthalmic Sales Breakdown by Type (2022-2027)
6.3 North America Anti-Infective Ophthalmic Sales Breakdown by Application
6.3.1 North America Anti-Infective Ophthalmic Sales Breakdown by Application (2016-2021)
6.3.2 North America Anti-Infective Ophthalmic Sales Breakdown by Application (2022-2027)
7 Europe Anti-Infective Ophthalmic Market Facts & Figures
7.1 Europe Anti-Infective Ophthalmic Sales by Company
7.1.1 Europe Anti-Infective Ophthalmic Sales by Company (2016-2021)
7.1.2 Europe Anti-Infective Ophthalmic Revenue by Company (2016-2021)
7.2 Europe Anti-Infective Ophthalmic Sales Breakdown by Type
7.2.1 Europe Anti-Infective Ophthalmic Sales Breakdown by Type (2016-2021)
7.2.2 Europe Anti-Infective Ophthalmic Sales Breakdown by Type (2022-2027)
7.3 Europe Anti-Infective Ophthalmic Sales Breakdown by Application
7.3.1 Europe 135 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 135 Sales Breakdown by Application (2022-2027)
8 China Anti-Infective Ophthalmic Market Facts & Figures
8.1 China Anti-Infective Ophthalmic Sales by Company
8.1.1 China Anti-Infective Ophthalmic Sales by Company (2016-2021)
8.1.2 China Anti-Infective Ophthalmic Revenue by Company (2016-2021)
8.2 China Anti-Infective Ophthalmic Sales Breakdown by Type
8.2.1 China Anti-Infective Ophthalmic Sales Breakdown by Type (2016-2021)
8.2.2 China Anti-Infective Ophthalmic Sales Breakdown by Type (2022-2027)
8.3 China Anti-Infective Ophthalmic Sales Breakdown by Application
8.3.1 China 244 Sales Breakdown by Application (2016-2021)
8.3.2 China 244 Sales Breakdown by Application (2022-2027)
9 Japan Anti-Infective Ophthalmic Market Facts & Figures
9.1 Japan Anti-Infective Ophthalmic Sales by Company
9.1.1 Japan Anti-Infective Ophthalmic Sales by Company (2016-2021)
9.1.2 Japan Anti-Infective Ophthalmic Revenue by Company (2016-2021)
9.2 Japan Anti-Infective Ophthalmic Sales Breakdown by Type
9.2.1 Japan Anti-Infective Ophthalmic Sales Breakdown by Type (2016-2021)
9.2.2 Japan Anti-Infective Ophthalmic Sales Breakdown by Type (2022-2027)
9.3 Japan Anti-Infective Ophthalmic Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Anti-Infective Ophthalmic Market Facts & Figures
10.1 Southeast Asia Anti-Infective Ophthalmic Sales by Company
10.1.1 Southeast Asia Anti-Infective Ophthalmic Sales by Company (2016-2021)
10.1.2 Southeast Asia Anti-Infective Ophthalmic Revenue by Company (2016-2021)
10.2 Southeast Asia Anti-Infective Ophthalmic Sales Breakdown by Type
10.2.1 Southeast Asia Anti-Infective Ophthalmic Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Anti-Infective Ophthalmic Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Anti-Infective Ophthalmic Sales Breakdown by Application
10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)
11 India Anti-Infective Ophthalmic Market Facts & Figures
11.1 India Anti-Infective Ophthalmic Sales by Company
11.1.1 India Anti-Infective Ophthalmic Sales by Company (2016-2021)
11.1.2 India Anti-Infective Ophthalmic Revenue by Company (2016-2021)
11.2 India Anti-Infective Ophthalmic Sales Breakdown by Type
11.2.1 India Anti-Infective Ophthalmic Sales Breakdown by Type (2016-2021)
11.2.2 India Anti-Infective Ophthalmic Sales Breakdown by Type (2022-2027)
11.3 India Anti-Infective Ophthalmic Sales Breakdown by Application
11.3.1 India Anti-Infective Ophthalmic Sales Breakdown by Application (2016-2021)
11.3.2 India Anti-Infective Ophthalmic Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Anti-Infective Ophthalmic Business
12.1 Novartis
12.1.1 Novartis Corporation Information
12.1.2 Novartis Business Overview
12.1.3 Novartis Anti-Infective Ophthalmic Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Novartis Anti-Infective Ophthalmic Products Offered
12.1.5 Novartis Recent Development
12.2 Allergan
12.2.1 Allergan Corporation Information
12.2.2 Allergan Business Overview
12.2.3 Allergan Anti-Infective Ophthalmic Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Allergan Anti-Infective Ophthalmic Products Offered
12.2.5 Allergan Recent Development
12.3 Bausch Health
12.3.1 Bausch Health Corporation Information
12.3.2 Bausch Health Business Overview
12.3.3 Bausch Health Anti-Infective Ophthalmic Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Bausch Health Anti-Infective Ophthalmic Products Offered
12.3.5 Bausch Health Recent Development
12.4 Santen Pharmaceutical
12.4.1 Santen Pharmaceutical Corporation Information
12.4.2 Santen Pharmaceutical Business Overview
12.4.3 Santen Pharmaceutical Anti-Infective Ophthalmic Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Santen Pharmaceutical Anti-Infective Ophthalmic Products Offered
12.4.5 Santen Pharmaceutical Recent Development
12.5 Lupin Pharmaceuticals
12.5.1 Lupin Pharmaceuticals Corporation Information
12.5.2 Lupin Pharmaceuticals Business Overview
12.5.3 Lupin Pharmaceuticals Anti-Infective Ophthalmic Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Lupin Pharmaceuticals Anti-Infective Ophthalmic Products Offered
12.5.5 Lupin Pharmaceuticals Recent Development
12.6 Apotex
12.6.1 Apotex Corporation Information
12.6.2 Apotex Business Overview
12.6.3 Apotex Anti-Infective Ophthalmic Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Apotex Anti-Infective Ophthalmic Products Offered
12.6.5 Apotex Recent Development
12.7 Akorn
12.7.1 Akorn Corporation Information
12.7.2 Akorn Business Overview
12.7.3 Akorn Anti-Infective Ophthalmic Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Akorn Anti-Infective Ophthalmic Products Offered
12.7.5 Akorn Recent Development
…
13 Anti-Infective Ophthalmic Manufacturing Cost Analysis
13.1 Anti-Infective Ophthalmic Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Anti-Infective Ophthalmic
13.4 Anti-Infective Ophthalmic Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Anti-Infective Ophthalmic Distributors List
14.3 Anti-Infective Ophthalmic Customers
15 Market Dynamics
15.1 Anti-Infective Ophthalmic Market Trends
15.2 Anti-Infective Ophthalmic Drivers
15.3 Anti-Infective Ophthalmic Market Challenges
15.4 Anti-Infective Ophthalmic Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Anti-Infective Ophthalmic Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Anti-Infective Ophthalmic Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Anti-Infective Ophthalmic Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Anti-Infective Ophthalmic Sales (K Units) by Region (2016-2021)
Table 5. Global Anti-Infective Ophthalmic Sales Market Share by Region (2016-2021)
Table 6. Global Anti-Infective Ophthalmic Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Anti-Infective Ophthalmic Revenue Share by Region (2016-2021)
Table 8. Global Anti-Infective Ophthalmic Sales (K Units) Forecast by Region (2022-2027)
Table 9. Global Anti-Infective Ophthalmic Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Anti-Infective Ophthalmic Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Anti-Infective Ophthalmic Revenue Share Forecast by Region (2022-2027)
Table 12. Global Anti-Infective Ophthalmic Sales (K Units) of Key Companies (2016-2021)
Table 13. Global Anti-Infective Ophthalmic Sales Share by Company (2016-2021)
Table 14. Global Anti-Infective Ophthalmic Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Anti-Infective Ophthalmic Revenue Share by Company (2016-2021)
Table 16. Global Anti-Infective Ophthalmic by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-Infective Ophthalmic as of 2020)
Table 17. Global Anti-Infective Ophthalmic Average Price (USD/Unit) of Key Company (2016-2021)
Table 18. Manufacturers Anti-Infective Ophthalmic Manufacturing Sites and Area Served
Table 19. Manufacturers Anti-Infective Ophthalmic Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Anti-Infective Ophthalmic Sales (K Units) by Type (2016-2021)
Table 22. Global Anti-Infective Ophthalmic Sales Share by Type (2016-2021)
Table 23. Global Anti-Infective Ophthalmic Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Anti-Infective Ophthalmic Price (USD/Unit) by Type (2016-2021)
Table 25. Global Anti-Infective Ophthalmic Sales Share by Type (2022-2027)
Table 26. Global Anti-Infective Ophthalmic Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Anti-Infective Ophthalmic Revenue Share by Type (2022-2027)
Table 28. Global Anti-Infective Ophthalmic Price (USD/Unit) by Type (2022-2027)
Table 29. Global Anti-Infective Ophthalmic Sales (K Units) by Application (2016-2021)
Table 30. Global Anti-Infective Ophthalmic Sales Share by Application (2016-2021)
Table 31. Global Anti-Infective Ophthalmic Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Anti-Infective Ophthalmic Price (USD/Unit) by Application (2016-2021)
Table 33. Global Anti-Infective Ophthalmic Sales (K Units) by Application (2022-2027)
Table 34. Global Anti-Infective Ophthalmic Sales Share by Application (2022-2027)
Table 35. Global Anti-Infective Ophthalmic Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Anti-Infective Ophthalmic Revenue Share by Application (2022-2027)
Table 37. Global Anti-Infective Ophthalmic Price (USD/Unit) by Application (2022-2027)
Table 38. North America Anti-Infective Ophthalmic Sales (K Units) by Company (2016-2021)
Table 39. North America Anti-Infective Ophthalmic Sales Market Share by Company (2016-2021)
Table 40. North America Anti-Infective Ophthalmic Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Anti-Infective Ophthalmic Revenue Market Share by Company (2016-2021)
Table 42. North America Anti-Infective Ophthalmic Sales by Type (2016-2021) & (K Units)
Table 43. North America Anti-Infective Ophthalmic Sales Market Share by Type (2016-2021)
Table 44. North America Anti-Infective Ophthalmic Sales by Type (2022-2027) & (K Units)
Table 45. North America Anti-Infective Ophthalmic Sales Market Share by Type (2022-2027)
Table 46. North America Anti-Infective Ophthalmic Sales by Application (2016-2021) & (K Units)
Table 47. North America Anti-Infective Ophthalmic Sales Market Share by Application (2016-2021)
Table 48. North America Anti-Infective Ophthalmic Sales by Application (2022-2027) & (K Units)
Table 49. North America Anti-Infective Ophthalmic Sales Market Share by Application (2022-2027)
Table 50. Europe Anti-Infective Ophthalmic Sales (K Units) by Company (2016-2021)
Table 51. Europe Anti-Infective Ophthalmic Sales Market Share by Company (2016-2021)
Table 52. Europe Anti-Infective Ophthalmic Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Anti-Infective Ophthalmic Revenue Market Share by Company (2016-2021)
Table 54. Europe Anti-Infective Ophthalmic Sales by Type (2016-2021) & (K Units)
Table 55. Europe Anti-Infective Ophthalmic Sales Market Share by Type (2016-2021)
Table 56. Europe Anti-Infective Ophthalmic Sales by Type (2022-2027) & (K Units)
Table 57. Europe Anti-Infective Ophthalmic Sales Market Share by Type (2022-2027)
Table 58. Europe Anti-Infective Ophthalmic Sales by Application (2016-2021) & (K Units)
Table 59. Europe Anti-Infective Ophthalmic Sales Market Share by Application (2016-2021)
Table 60. Europe Anti-Infective Ophthalmic Sales by Application (2022-2027) & (K Units)
Table 61. Europe Anti-Infective Ophthalmic Sales Market Share by Application (2022-2027)
Table 62. China Anti-Infective Ophthalmic Sales (K Units) by Company (2016-2021)
Table 63. China Anti-Infective Ophthalmic Sales Market Share by Company (2016-2021)
Table 64. China Anti-Infective Ophthalmic Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Anti-Infective Ophthalmic Revenue Market Share by Company (2016-2021)
Table 66. China Anti-Infective Ophthalmic Sales by Type (2016-2021) & (K Units)
Table 67. China Anti-Infective Ophthalmic Sales Market Share by Type (2016-2021)
Table 68. China Anti-Infective Ophthalmic Sales by Type (2022-2027) & (K Units)
Table 69. China Anti-Infective Ophthalmic Sales Market Share by Type (2022-2027)
Table 70. China Anti-Infective Ophthalmic Sales by Application (2016-2021) & (K Units)
Table 71. China Anti-Infective Ophthalmic Sales Market Share by Application (2016-2021)
Table 72. China Anti-Infective Ophthalmic Sales by Application (2022-2027) & (K Units)
Table 73. China Anti-Infective Ophthalmic Sales Market Share by Application (2022-2027)
Table 74. Japan Anti-Infective Ophthalmic Sales (K Units) by Company (2016-2021)
Table 75. Japan Anti-Infective Ophthalmic Sales Market Share by Company (2016-2021)
Table 76. Japan Anti-Infective Ophthalmic Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Anti-Infective Ophthalmic Revenue Market Share by Company (2016-2021)
Table 78. Japan Anti-Infective Ophthalmic Sales by Type (2016-2021) & (K Units)
Table 79. Japan Anti-Infective Ophthalmic Sales Market Share by Type (2016-2021)
Table 80. Japan Anti-Infective Ophthalmic Sales by Type (2022-2027) & (K Units)
Table 81. Japan Anti-Infective Ophthalmic Sales Market Share by Type (2022-2027)
Table 82. Japan Anti-Infective Ophthalmic Sales by Application (2016-2021) & (K Units)
Table 83. Japan Anti-Infective Ophthalmic Sales Market Share by Application (2016-2021)
Table 84. Japan Anti-Infective Ophthalmic Sales by Application (2022-2027) & (K Units)
Table 85. Japan Anti-Infective Ophthalmic Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Anti-Infective Ophthalmic Sales (K Units) by Company (2016-2021)
Table 87. Southeast Asia Anti-Infective Ophthalmic Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Anti-Infective Ophthalmic Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Anti-Infective Ophthalmic Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Anti-Infective Ophthalmic Sales by Type (2016-2021) & (K Units)
Table 91. Southeast Asia Anti-Infective Ophthalmic Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Anti-Infective Ophthalmic Sales by Type (2022-2027) & (K Units)
Table 93. Southeast Asia Anti-Infective Ophthalmic Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Anti-Infective Ophthalmic Sales by Application (2016-2021) & (K Units)
Table 95. Southeast Asia Anti-Infective Ophthalmic Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Anti-Infective Ophthalmic Sales by Application (2022-2027) & (K Units)
Table 97. Southeast Asia Anti-Infective Ophthalmic Sales Market Share by Application (2022-2027)
Table 98. India Anti-Infective Ophthalmic Sales (K Units) by Company (2016-2021)
Table 99. India Anti-Infective Ophthalmic Sales Market Share by Company (2016-2021)
Table 100. India Anti-Infective Ophthalmic Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Anti-Infective Ophthalmic Revenue Market Share by Company (2016-2021)
Table 102. India Anti-Infective Ophthalmic Sales by Type (2016-2021) & (K Units)
Table 103. India Anti-Infective Ophthalmic Sales Market Share by Type (2016-2021)
Table 104. India Anti-Infective Ophthalmic Sales by Type (2022-2027) & (K Units)
Table 105. India Anti-Infective Ophthalmic Sales Market Share by Type (2022-2027)
Table 106. India Anti-Infective Ophthalmic Sales by Application (2016-2021) & (K Units)
Table 107. India Anti-Infective Ophthalmic Sales Market Share by Application (2016-2021)
Table 108. India Anti-Infective Ophthalmic Sales by Application (2022-2027) & (K Units)
Table 109. India Anti-Infective Ophthalmic Sales Market Share by Application (2022-2027)
Table 110. Novartis Corporation Information
Table 111. Novartis Description and Business Overview
Table 112. Novartis Anti-Infective Ophthalmic Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 113. Novartis Anti-Infective Ophthalmic Product
Table 114. Novartis Recent Development
Table 115. Allergan Corporation Information
Table 116. Allergan Description and Business Overview
Table 117. Allergan Anti-Infective Ophthalmic Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 118. Allergan Anti-Infective Ophthalmic Product
Table 119. Allergan Recent Development
Table 120. Bausch Health Corporation Information
Table 121. Bausch Health Description and Business Overview
Table 122. Bausch Health Anti-Infective Ophthalmic Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 123. Bausch Health Anti-Infective Ophthalmic Product
Table 124. Bausch Health Recent Development
Table 125. Santen Pharmaceutical Corporation Information
Table 126. Santen Pharmaceutical Description and Business Overview
Table 127. Santen Pharmaceutical Anti-Infective Ophthalmic Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 128. Santen Pharmaceutical Anti-Infective Ophthalmic Product
Table 129. Santen Pharmaceutical Recent Development
Table 130. Lupin Pharmaceuticals Corporation Information
Table 131. Lupin Pharmaceuticals Description and Business Overview
Table 132. Lupin Pharmaceuticals Anti-Infective Ophthalmic Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 133. Lupin Pharmaceuticals Anti-Infective Ophthalmic Product
Table 134. Lupin Pharmaceuticals Recent Development
Table 135. Apotex Corporation Information
Table 136. Apotex Description and Business Overview
Table 137. Apotex Anti-Infective Ophthalmic Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 138. Apotex Anti-Infective Ophthalmic Product
Table 139. Apotex Recent Development
Table 140. Akorn Corporation Information
Table 141. Akorn Description and Business Overview
Table 142. Akorn Anti-Infective Ophthalmic Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 143. Akorn Anti-Infective Ophthalmic Product
Table 144. Akorn Recent Development
Table 145. Production Base and Market Concentration Rate of Raw Material
Table 146. Key Suppliers of Raw Materials
Table 147. Anti-Infective Ophthalmic Distributors List
Table 148. Anti-Infective Ophthalmic Customers List
Table 149. Anti-Infective Ophthalmic Market Trends
Table 150. Anti-Infective Ophthalmic Market Drivers
Table 151. Anti-Infective Ophthalmic Market Challenges
Table 152. Anti-Infective Ophthalmic Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Anti-Infective Ophthalmic Product Picture
Figure 2. Global Anti-Infective Ophthalmic Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Anti-Infective Ophthalmic Sales Market Share by Application in 2021 & 2027
Figure 6. Hospital Examples
Figure 7. Clinic Examples
Figure 8. Household Examples
Figure 9. Others Examples
Figure 10. Global Anti-Infective Ophthalmic Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Anti-Infective Ophthalmic Sales Growth Rate (2016-2027) & (US$ Million)
Figure 12. Global Anti-Infective Ophthalmic Sales (K Units) Growth Rate (2016-2027)
Figure 13. Global Anti-Infective Ophthalmic Price Trends Growth Rate (2016-2027) (USD/Unit)
Figure 14. Global Anti-Infective Ophthalmic Revenue Market Share by Region: 2016 VS 2021
Figure 15. Global Anti-Infective Ophthalmic Revenue Market Share by Region: 2021 VS 2027
Figure 16. North America Anti-Infective Ophthalmic Revenue (Million USD) Growth Rate (2016-2027)
Figure 17. North America Anti-Infective Ophthalmic Sales (K Units) Growth Rate (2016-2027)
Figure 18. Europe Anti-Infective Ophthalmic Revenue (Million USD) Growth Rate (2016-2027)
Figure 19. Europe Anti-Infective Ophthalmic Sales (Million USD) Growth Rate (2016-2027)
Figure 20. China Anti-Infective Ophthalmic Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. China Anti-Infective Ophthalmic Sales (Million USD) and Growth Rate (2016-2027)
Figure 22. Japan Anti-Infective Ophthalmic Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. Japan Anti-Infective Ophthalmic Sales (Million USD) Growth Rate (2016-2027)
Figure 24. Southeast Asia Anti-Infective Ophthalmic Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. Southeast Asia Anti-Infective Ophthalmic Sales (Million USD) Growth Rate (2016-2027)
Figure 26. India Anti-Infective Ophthalmic Revenue (Million USD) Growth Rate (2016-2027)
Figure 27. India Anti-Infective Ophthalmic Sales (Million USD) Growth Rate (2016-2027)
Figure 28. Global 5 Largest Anti-Infective Ophthalmic Players Market Share by Revenue in Anti-Infective Ophthalmic: 2016 & 2020
Figure 29. Anti-Infective Ophthalmic Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 30. Global Anti-Infective Ophthalmic Revenue Share by Type (2016-2021)
Figure 31. Global Anti-Infective Ophthalmic Revenue Growth Rate by Type in 2016 & 2020
Figure 32. Global Anti-Infective Ophthalmic Revenue Share by Application (2016-2021)
Figure 33. Global Anti-Infective Ophthalmic Revenue Growth Rate by Application in 2016 & 2020
Figure 34. North America Anti-Infective Ophthalmic Sales Market Share by Type in 2020
Figure 35. North America Anti-Infective Ophthalmic Sales Market Share by Application in 2020
Figure 36. Europe Anti-Infective Ophthalmic Sales Market Share by Type in 2020
Figure 37. Europe Anti-Infective Ophthalmic Sales Market Share by Application in 2020
Figure 38. China Anti-Infective Ophthalmic Sales Market Share by Type in 2020
Figure 39. China Anti-Infective Ophthalmic Sales Market Share by Application in 2020
Figure 40. Japan Anti-Infective Ophthalmic Sales Market Share by Type in 2020
Figure 41. Japan Anti-Infective Ophthalmic Sales Market Share by Application in 2020
Figure 42. Southeast Asia Anti-Infective Ophthalmic Sales Market Share by Type in 2020
Figure 43. Southeast Asia Anti-Infective Ophthalmic Sales Market Share by Application in 2020
Figure 44. India Anti-Infective Ophthalmic Sales Market Share by Type in 2020
Figure 45. India Anti-Infective Ophthalmic Sales Market Share by Application in 2020
Figure 46. Key Raw Materials Price Trend
Figure 47. Manufacturing Cost Structure of Anti-Infective Ophthalmic
Figure 48. Manufacturing Process Analysis of Anti-Infective Ophthalmic
Figure 49. Anti-Infective Ophthalmic Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed